We are live on
!
Find out more
CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
1-Year Est. Return
43.59%
This Fund
S&P 500
This Quarter
Est. Return
+31.63%
1 Year Est. Return
-43.59%
3 Year Est. Return
+313.86%
5 Year Est. Return
+886.32%
10 Year Est. Return
–
AUM
$1.58B
AUM Growth
+$225M
(+17%)
Cap. Flow
+$66.3M
Cap. Flow
% of AUM
4.18%
Top 10 Holdings %
Top 10 Hldgs %
72.95%
Holding
32
New
8
Increased
10
Reduced
2
Closed
6
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals
AERI
|
+$74.7M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
+$38.9M |
| 3 |
Omeros
OMER
|
+$30.6M |
| 4 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
+$29.3M |
| 5 |
Myriad Genetics
MYGN
|
+$28.6M |
Top Sells
| 1 |
Exelixis
EXEL
|
+$131M |
| 2 |
LMNX
Luminex Corp
LMNX
|
+$55.5M |
| 3 |
Corcept Therapeutics
CORT
|
+$30.6M |
| 4 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
+$26M |
| 5 |
Pacific Biosciences
PACB
|
+$18.2M |
Sector Composition
| 1 | Healthcare | 92.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$297M
| $228M | 14.4% |
549,549
+77,011
| +16% | +$27.8M |
|
2
United Therapeutics
UTHR
$22.5B
| $144M | 9.08% |
1,225,387
+124,790
| +11% | +$14.5M |
|
3
Pacira BioSciences
PCRX
$1.01B
| $139M | 8.77% |
3,652,134
| – | – |
|
4
uniQure
QURE
$2.71B
| $118M | 7.48% |
1,985,460
+89,234
| +5% | +$3.99M |
|
|
5
Myriad Genetics
MYGN
$585M
| $110M | 6.94% |
3,309,206
+938,910
| +40% | +$28.6M |
|
6
Travere Therapeutics
TVTX
$5.14B
| $91.2M | 5.76% |
4,032,123
| – | – |
|
7
Catalyst Pharmaceutical
CPRX
| $91.2M | 5.75% |
17,875,655
+8,473,338
| +90% | +$24.9M |
|
|
AERI
8
DELISTED
Aerie Pharmaceuticals
AERI
| $80.6M | 5.09% |
+1,696,773
| New | +$74.7M |
|
9
Vanda Pharmaceuticals
VNDA
$328M
| $78.4M | 4.95% |
4,258,358
-400,401
| -9% | -$9.12M |
|
10
Vericel Corp
VCEL
$2.44B
| $75.1M | 4.74% |
4,288,092
+70,000
| +2% | +$1.28M |
|
11
UroGen Pharma
URGN
$1.95B
| $65M | 4.1% |
1,759,324
+243,902
| +16% | +$10.2M |
|
|
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $44.9M | 2.84% |
2,608,784
+29,000
| +1% | +$459K |
|
|
13
Corcept Therapeutics
CORT
$9.63B
| $44M | 2.78% |
3,747,453
-2,464,511
| -40% | -$30.6M |
|
|
EPZM
14
DELISTED
Epizyme, Inc
EPZM
| $43.1M | 2.72% |
+3,478,261
| New | +$38.9M |
|
|
15
Omeros
OMER
$667M
| $36.9M | 2.33% |
+2,124,619
| New | +$30.6M |
|
|
KDMN
16
DELISTED
Kadmon Holdings, Inc.
KDMN
| $30.7M | 1.94% |
+11,627,900
| New | +$29.3M |
|
17
Karyopharm Therapeutics
KPTI
$213M
| $30.1M | 1.9% |
343,926
+23,254
| +7% | +$2.58M |
|
18
Aurinia Pharmaceuticals
AUPH
$2.05B
| $27.4M | 1.73% |
4,222,558
+4,212,558
| +42,126% | +$27.9M |
|
|
CCXI
19
DELISTED
ChemoCentryx, Inc.
CCXI
| $23.1M | 1.46% |
+1,666,667
| New | +$19.1M |
|
20
Savara
SVRA
$1.13B
| $22.8M | 1.44% |
3,093,690
| – | – |
|
21
ADMA Biologics
ADMA
$2.04B
| $17.4M | 1.1% |
4,588,352
| – | – |
|
22
Akebia Therapeutics
AKBA
$376M
| $11.7M | 0.74% |
+1,430,579
| New | +$9.82M |
|
23
Iovance Biotherapeutics
IOVA
$2.08B
| $10.8M | 0.68% |
+1,140,000
| New | +$11.1M |
|
24
ANI Pharmaceuticals
ANIP
$1.86B
| $10.1M | 0.64% |
142,943
| – | – |
|
|
IMMU
25
DELISTED
Immunomedics Inc
IMMU
| $2.79M | 0.18% |
+145,000
| New | +$2.34M |
|
Similar funds
GPC
BPM
TVPI
DCI
TPMI
TP
SCG
CVGI